Posted by Michael Wonder on 21 Jun 2021
Are drugs priced in accordance with value? A comparison of value based and net prices using Institute for Clinical and Economic Review reports
19 June 2021 - The Institute for Clinical and Economic Review is an independent organisation that reviews drugs and devices with a focus on emerging agents.
As part of their evaluation, ICER estimates value based prices at $50,000 - $150,000 per quality-adjusted life year gained thresholds.
Actual estimated net prices to ICER estimated value based prices were compared.
